Patent details

Basic Information

Publication number:

EP3334432

PCT Application Number:

US2016046862

Type:

European Patent Granted for LU

Legal Status:

Lapsed

Application number:

EP168359958

PCT Publication Number:

WO2017027829

First applicant's nationality:

Translation Language:

EPO Publication Language:

English

English Title of Invention:

CERDULATINIB FOR TREATING MYELOMA

French Title of Invention:

CERDULATINIB POUR LE TRAITEMENT DU MYÉLOME

German Title of Invention:

CERDULATINIB ZUR BEHANDLUNG VON MYELOM

SPC Number:

Dates

Filing date:

12/08/2016

Grant date:

23/02/2022

EP Publication Date:

20/06/2018

PCT Publication Date:

16/02/2017

Claims Translation Received Date:

Translations Received Date (B1 EP Publication):

Translations Received Date (B2 EP Publication):

Translations Received Date (B3 EP Publication):

Publication date:

23/02/2022

EP B1 Publication Date:

23/02/2022

EP B2 Publication Date:

EP B3 Publication Date:

Lapsed date:

12/08/2022

Expiration date:

12/08/2036

Renunciation date:

Revocation date:

Annulment date:

Owner

From:

16/02/2022

 

 

Name:

Portola Pharmaceuticals, Inc.

Address:

270 East Grand Avenue Suite 22, South San Francisco, California 94080, United States (US)

Inventor

1

Name:

COFFEY, Gregory

Address:

United States (US)

2

Name:

FENG, Jiajia

Address:

United States (US)

Priority

1

Priority Number:

201562204400 P

Priority Date:

12/08/2015

Priority Country:

United States (US)

2

Priority Number:

201662342711 P

Priority Date:

27/05/2016

Priority Country:

United States (US)

Classification

IPC classification:

A61K 31/506; A61K 31/551; C07D 279/12; A61K 45/06; A61P 35/02;

Publication

European Patent Bulletin

Issue number:

202208

Publication date:

23/02/2022

Description:

Grant (B1)

Annual Fees

Annual Fee Due Date:

Annual Fee Number:

Expected Payer:

Last Annual Fee Payment Date:

Last Annual Fee Paid Number:

Payer:

Filing date	Document type	Number of pages